Do Human Chorionic Gonadotropin (HCG) levels change in twin pregnancies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HCG Levels in Twin Pregnancies

Yes, HCG levels are significantly higher in twin pregnancies compared to singleton pregnancies, typically about twice as high throughout gestation. This elevation is directly related to the increased placental mass present in multiple gestations.

HCG Patterns in Twin Pregnancies

First Trimester

  • Beta-HCG levels in twin pregnancies are approximately twice as high as singleton pregnancies during the first trimester 1
  • At 13 days after embryo transfer in assisted reproduction pregnancies, beta-HCG is significantly higher in twins compared to singletons 1
  • At 10-14 weeks gestation, the median free beta-HCG in normal twin pregnancies (65 ng/mL) is about twice as high as in singleton pregnancies (34 ng/mL) 2

Second Trimester

  • Maternal serum free beta-HCG levels are approximately 1.8-2.2 times higher in twin pregnancies compared to singleton pregnancies 3, 4
  • In one study, HCG levels were found to be 2.5 times higher throughout gestation in twin pregnancies compared to singletons 5

Clinical Implications

Prenatal Screening

  • The elevated HCG levels in twin pregnancies affect prenatal screening calculations for conditions like Down syndrome 6
  • Standard cut-off levels used for singleton pregnancies cannot be directly applied to twin pregnancies 6
  • When performing Down syndrome screening, laboratories must account for the number of fetuses as this affects the interpretation of serum marker levels 6

Laboratory Considerations

  • Laboratories need to be informed of multiple gestations when interpreting serum marker results 6
  • Algorithms for assigning pregnancy-specific risk when combining nuchal translucency measurements and biochemistry have been published that take into account the zygosity of twins by observing chorionicity 6

Important Distinctions

Dichorionic vs. Monochorionic Twins

  • The levels of serum markers in twin pregnancies are pregnancy-specific rather than fetus-specific 6
  • In contrast, nuchal translucency (NT) measurements are fetus-specific and can be assessed individually 6
  • Overall, Down syndrome screening in twin pregnancies is less effective than for singleton pregnancies 6

IVF vs. Spontaneous Twin Pregnancies

  • IVF twin pregnancies may have even higher beta-HCG levels (median 2.20 MoM) compared to spontaneous twins (median 1.83 MoM) 3
  • This difference should be considered in Down syndrome screening to avoid high false positive rates 3

Clinical Monitoring Recommendations

  • Multiple gestations require more intensive monitoring than singleton pregnancies 7
  • Most women with multiple gestations should undergo, at minimum: first trimester dating scan, nuchal translucency scan at 11-14 weeks, anatomy scan at 18-22 weeks, and one or more third-trimester growth scans 7

The elevated HCG levels in twin pregnancies reflect the increased placental mass and are an important consideration in prenatal screening and monitoring. Healthcare providers should ensure that laboratories are informed about multiple gestations to allow for appropriate interpretation of serum marker results.

References

Research

Serum HCG and HPL in twin pregnancies.

Acta obstetricia et gynecologica Scandinavica, 1977

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Obstetrical Reporting Guidelines for Multiple Births

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.